ClinicalTrials.gov
ClinicalTrials.gov Menu

Entecavir Versus Lamivudine for Preventing the Risk of Hepatitis B Reactivation in NHL

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01914744
Recruitment Status : Unknown
Verified July 2013 by Ye Guo, Fudan University.
Recruitment status was:  Recruiting
First Posted : August 2, 2013
Last Update Posted : August 2, 2013
Sponsor:
Information provided by (Responsible Party):
Ye Guo, Fudan University

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : December 2015
  Estimated Study Completion Date : December 2016